Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Anti-Infective Agents* ; Cross Infection*/prevention & control; Delivery of Health Care ; Humans ; Italy ; Pilot Projects

Background: Italy records very alarming levels antimicrobial resistance (AMR), so a National Action Plan on Antimicrobial resistance (PNCAR) was developed, adopting the AMR European Union's recommendations based on the results of the ECDC site visit of January 2017. For achieving PNCAR objectives, it is necessary to support and harmonize the implementation of recommendations in all the different healthcare levels (regional authorities and local trusts), so the SPiNCAR project was launched to create a tool for reaching this goal.
Methods: We developed a framework based on a scientific literature and national and international guidelines. Firstly, we identified the major intervention areas for tackling AMR, then, for each area, we built a set of standards, both for regional authorities than for local trusts. Every standard is composed by a set of essential and additional criteria, which refer to a minimum or supplemental performance level respectively. The contents were firstly discussed by the project's team during face-to-face kick-off meetings, then confirmed with Delphi methodology and finally validated through a pilot study.
Results: The final framework consists of seven different areas that reflect the PNCAR structure: Governance, Surveillance and Monitoring, Appropriate Use of antimicrobials, Healthcare-associated Infections (HAIs) control and prevention, Education and Training, Alliance among Stakeholders, Implementation. The total number of standards for the regional framework was 34 with 264 criteria and for the local version 36 criteria with 279 standards.
Conclusion: The ongoing use of this tool, developed on international evidences and recommendations that were tailored on the Italian specific context, allows monitoring the improvement achieved over time and plan the next steps.
Competing Interests: The authors have declared that no competing interests exist.

Int J Health Care Qual Assur. 2016 Aug 8;29(7):744-58. (PMID: 27477931)
Euro Surveill. 2018 Nov;23(46):. (PMID: 30458917)
J Health Serv Res Policy. 1999 Oct;4(4):236-48. (PMID: 10623041)
Lancet Infect Dis. 2019 Nov;19(11):e371-e384. (PMID: 31588040)
Lancet Infect Dis. 2020 Dec;20(12):e307-e311. (PMID: 32853549)
Antimicrob Resist Infect Control. 2018 Apr 25;7:58. (PMID: 29713465)
BMJ. 1995 Aug 5;311(7001):376-80. (PMID: 7640549)
Euro Surveill. 2018 Nov;23(46):. (PMID: 30458913)
EFSA J. 2018 Feb 27;16(2):e05182. (PMID: 32625816)
Lancet Infect Dis. 2019 Jan;19(1):56-66. (PMID: 30409683)

0 (Anti-Infective Agents)

Date Created: 20220310 Date Completed: 20220427 Latest Revision: 20220427

20221216

PMC8912127

10.1371/journal.pone.0265010

35271635